NUZ neurizon therapeutics limited

NUZ -- New Investor thread, page-1648

  1. 2,992 Posts.
    lightbulb Created with Sketch. 2017
    Thanks Densy,
    I thought that may be the case, and if my understanding is correct it marks a significant step. For those who may be curious of the implications.

    Understanding "Disease-Modifying" vs. "Treatment" Language

    Regulatory and Clinical Significance

    The distinction between "disease-modifying" and "symptomatic treatment" carries significant regulatory and clinical implications

    . A disease-modifying treatment is one that delays, slows, or reverses the progression of a disease by targeting its underlying cause, while symptomatic treatments address symptoms without affecting the disease's underlying pathophysiology.


    Have a great weekend.


    Cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.5¢
Change
0.005(2.94%)
Mkt cap ! $86.15M
Open High Low Value Volume
17.0¢ 18.5¢ 16.5¢ $91.76K 527.0K

Buyers (Bids)

No. Vol. Price($)
4 80407 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 31 1
View Market Depth
Last trade - 15.34pm 20/06/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.